This report report provides a detailed overview of the major drivers, restraints, opportunities, and threat impacting the global top 10 bioprocess technology market along with the estimates and forecasts of the revenue and market share analysis.
- Advertising -
Browse 219 market data tables and 46 figures spread through 257 pages and in-depth TOC on “Top 10 Bioprocess Technology Market"
The top 10 bioprocess technology market is expected to USD 71.03 Billion by 2021 from USD 39.30 Billion in 2016, at a CAGR of 12.4% between 2016 and 2021.
Growth in the biopharmaceutical industry, increase in R&D spending, rising demand for vaccine production, and technological advancements form important growth drivers for this market during the forecast period. The rising opportunities in emerging market and increasing pharmaceutical outsourcing provide significant growth opportunities for players operating in the top 10 bioprocess technology market.
- Advertising -
On the basis of type, the market is segmented into cell culture, cell expansion, cell counting, cell line development, flow cytometry, single-use bioprocessing, biologics safety testing, virus filtration, tangential flow filtration, and pyrogen testing. In 2016, the cell culture segment is expected to account for the largest share of the global top 10 bioprocess technology market.
The largest share of this segment is primarily attributed to the repeated purchase of consumables as compared to equipment and increase in funding for cell-based research.
Download the PDF Brochure at www.marketsandmarkets.com/pdfdownload.asp?id=30722776
On the basis of region, the market is segmented into North America, Europe, Asia, and RoW. The report maps each bioprocess technology in these geographic and regional segments.
In 2016, North America is expected to account for the largest share of the global top 10 bioprocess technology market. Growth in this market can be attributed to the increase in demand of high quality biologics and rising spending on R&D by top players in this region.
Similarly, Asia is estimated to grow at the highest CAGR during the forecast period. The wide applications of bioprocess technology in the biopharmaceutical and pharmaceutical industry are expected to drive the demand for top 10 bioprocess technology market in this region.
A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global top 10 bioprocess technology market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.
In 2016, North America accounted for the largest share of the global top 10 bioprocess technology market. Growth in this market can be attributed to the increase in demand of high quality biologics, rising spending on R&D by top players in this region.
Similarly, Asia is estimated to grow at the highest CAGR during the forecast period. The growth of this market is fueled by overall growth in the biopharmaceutical industry, investments by key market players in Asia countries, increasing government support, developments in R&D infrastructure, increasing outsourcing to Asia countries, and growing expertise and academic excellence in Asia.
The prominent players in the top 10 bioprocess technology market include GE Healthcare (U.S.), Merck Millipore (Germany), Thermo Fisher Scientific, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), Lonza Group AG (Switzerland), Sartorius Stedim Biotech S.A (France), Corning, Inc.(U.S.), Bio-Rad Laboratories (U.S.), and Charles River Laboratories (U.S.).
Category: Market Research Publishers and RetailersCompany about: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...